1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of boneEvdokiou, A.; Atkins, G.; Bouralexis, S.; Hay, S.; Raggatt, L.; Cowled, P.; Graves, S.; Clayer, J.; Findlay, D.
2001Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic jointHaynes, D.; Crotti, T.; Loric, M.; Bain, G.; Atkins, G.; Findlay, D.
2001Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kB ligand and macrophage colony-stimulating factorWada, S.; Yasuda, S.; Nagai, T.; Maeda, T.; Kitahama, S.; Suda, S.; Findlay, D.; Iitaka, M.; Katayama, S.
2001Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAILClayer, M.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Atkins, G.; Findlay, D.
2001The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysisHaynes, D.; Crotti, T.; Potter, A.; Loric, M.; Atkins, G.; Howie, D.; Findlay, D.
2001Differential Gene Expression in the Human Bone Microenvironment of the Hip; Comparison Between Control and Osteoarthritis.Atkins, G.; Kuliwaba, J.; Findlay, D.; Forwood, M.; Fazzalari, N.; Asia Pacific Orthopaedic Association. Conference (2001 : Adelaide, South Australia)
2001Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosisFindlay, D.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Evdokiou, A.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2001Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of boneAtkins, G.; Bouralexis, S.; Haynes, D.; Graves, S.; Geary, S.; Evdokiou, A.; Zannettino, A.; Hay, S.; Findlay, D.
2001The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritisFazzalari, N.; Kuliwaba, J.; Atkins, G.; Forwood, M.; Findlay, D.

Discover